It is with great pleasure that we invite all to participate on our SNOLA 2018 – The State of the Art in Neuro-Oncology, which will take place on the 15th to 17th of March 2018 at the hotel Tivoli Mofarrej, São Paulo/Brazil. Just as the 2016 event, this will be the largest and most comprehensive event on neuro-oncology in Latin America.
Our first official SNOLA conference, the Update on Neuro-Oncology, happened in March 2016 in Rio de Janeiro and hosted more than 20 international speakers, and almost 600 attendees. The feedback from those that were present could not have been better, as our overall median score on satisfaction was 8.74, and the percentage that would recommend such event to a colleague reached 99.3%. This achievement was conquered despite all the difficulties we know this multidisciplinary field constantly faces, both in its scientific and practical terms.
Given the above, we again tried elaborating an event with a broad focus on the major oncological pathologies of the central nervous system, involving all areas that assist neuro-oncology patients, as neuro imaging, neuro pathology, neurologists, neuro surgeons, oncologists, radiotherapists, physiatrists, palliative care, and assisting crew. Moreover, we will have a great highlight given to the political and economic forum in order to discuss problems and reasonable solutions for neuro-oncology.
During this conference, we have great honor in receiving the support and participation of the World Federation of Neuro-Oncology Societies, society we are affiliated to together with SNO, EANO and ASNO, representing and developing neuro-oncology in Latin America.
We are pleased to develop a complete program, with more than 15 prominent international speakers on the area and count on the participation and engagement of all so that our great mission contributes to the growth, enhancement and scientificism of neuro-oncology in Latin America as a whole, aiming for the best assisted care to our suffering patients.
We hope seeing you all at the amazing city that never stops in order to continue writing a new page in the history of neuro-oncology.
May all of you feel welcome!!
Dr. Marcos Maldaun
President of the Event and SNOLA
CNS tumors rank second among childhood cancers, with around 20% of the cases occurring in this age group. These tumors are highly complex because they affect different sites and their histologic types vary. For these reasons, a multidisciplinary team with the scientific knowledge, technical expertise working together to reach excellence in treatment is required. This is the purpose of SNOLA 2018 – State of the Art in Neuro-Oncology, that will gather leading medical and pediatric oncologists, neurosurgeons, pathologists, radiotherapists, radiologists, among others, to have an integrated discussion on updates in neuro-oncology practice with the ultimate goal of providing better treatment to these patients.
Pediatric Oncology Chair
We are very pleased to host the State of the Art in Neuro-Oncology conference in São Paulo, Brazil, in 2018. This important conference will bring together opinion makers from several countries to discuss the most relevant aspects regarding neuro-oncological patients.
Multidisciplinary work is key for neurosurgeons, radiation oncologists, medical oncologists, radiologists, pathologists to provide the best possible epidemiology, diagnosis and treatment of tumors involving the nervous system. This pleiad of experts will also present future directions for new therapies, including gene therapies, immunotherapies and targeted therapies.
The conference format, which in addition to lectures will include case discussions and pro and con sessions, will provide useful information that can be applied to our daily practice.
Welcome to SNOLA 2018!
Fernando Cotait Maluf
Chair of Medical Oncology
Receiving a CNS tumor diagnosis can have an unmeasurable impact on the life of a person. Once with such news, an ambiguous and uncertain feeling usually arises.
The effective treatment possibilities for such tumors have been expanding considerably. Cure possibilities or an extension of life expectancy are today tangible possibilities for some. On the other hand, the concern with the suffering caused by the disease or by some of the treatments continues to threaten the integrity of patients and their relatives.
Palliative care, given the World Health Organization’s definition, is an approach to care for the suffering of who is sick, regardless of prognosis. Applied in a technical and specialized manner, as indicated by the best proofs, it helps the symptoms control, improves life quality, reduces costs and, in some cases, extends the life expectancy. And, in the most complex sceneries like those faced by patients, relatives and professionals that confront a CNS tumor, the integration of palliative care to the cancer treatment is an additional challenge. How can this be done best? How will this be done in the future? These answers still do not exist, but emerge in the present. Ideas arise during debates and experience exchange, and also from the different perspectives of those who are involved with these queries. Nothing better than an opportunity like what will happen during the SNOLA 2018 to nurture seeds and fruits for our future so that when patients, relatives and professionals are making their way through these rough roads, they can always be supported by the best treatments for the diseases and by the best care for people.Welcome to the SNOLA 2018 Conference – The State of the Art in Neuro-Oncology, and to the future that we will build together today.
Palliative Care Chair
We have elaborated for the SNOLA 2018 Conference a programme driven by the brain tumor diagnosis and monitoring, including advanced techniques of imaging in gliomas, correlating these with the new WHO classification, linfoma imaging, childhood tumors, meningiomas, skull base tumor, hypophyseal and paraselar tumors, medular tumors, multiple myeloma and metastasis, and others.
We will focus on the role of the imaging methods in surgical planning and neuro-oncology treatment, utilizing tractography, functional magnetic resonance and MR peri-operative.
We count with some of the biggest national neuro radiology names. More than the specific courses inclined to neuro-imaging, neuro radiology will be integrated in the master classes, interactive sessions, and during sessions that correlate image and neuropathology.
We count on your participation!
Neuro-oncology is a vibrant and current specialty in which medical neurologists, medical oncologists, neurosurgeons and radiation oncologists must face the great challenge of providing the latest treatment to every patient. The latest treatment does not necessarily mean the most sophisticated, the most expensive or the most invasive treatment, but it must aim at the highest likelihood of cure and the best quality of survival.
Due to the complexity of the treatment of patients with central nervous system tumors, a multidisciplinary approach should be used and managements should be guided by evidence-based medicine. According to this concept, information is precious and the exchange of experiences is crucial.
Quality of life is fundamental and excessive treatment, resulting in side effects that are beyond acceptable by patients and that exhaust the family both emotionally and financially, should be avoid. Instead, patients should be treated holistically, with healthcare practitioners, such as physicians from other specialties, oncology nurses, psychologists, physical therapists, speech therapists, dieticians, among others, working together so that we can achieve our goals.
SNOLA 2018, as in its previous edition, will focus not only on information on what is the best treatment in 2018 for patients with a central nervous system tumor, but also on how to provide these patients and their families the best support possible.
Radiosurgery is a mature oncology therapy, which its striking impact on life quality and overall survival of millions of patients has been widely reported in the last 64 years. The concept of focusing ionizing radiation on an intracerebral target with no need of opening the skull, in a minimally invasive manner and with low morbidity rate, was conceived by the Swiss neurosurgeon Lars Leksell in 1951. It is a multidisciplinary technique, just as neuro-oncology, involving neurosurgeons, radio-oncologists and physicists. Radiosurgery evolved with the computer and image development, allowing early diagnosis of brain lesions, still with no mass effect, therefore susceptible to be treated in a noninvasive manner.
The radiosurgery technique is robust, reproducible, efficient and safe. It revolutionary the way of treating brain metastasis. We can prevent total irradiation of the brain and also conventional microsurgery if the diagnosis of the brain disease is made in advance, offering high levels of local disease control with no need of hospitalization. The treatment can be repeated for new lesions that may appear given the patient’s overall survival. For these patients, the word time, so precious to all of us, takes over an more special and dramatic dimension, ensuring they have time to enjoy the company of their relatives with life quality. To be able to offer outpatient care is unique and worthwhile. We also minimize the risk of dementia development by leucoencefalopatia in “victorious” patients, those with extended overall survival or cured from the oncological diseases. Nowadays, between 16-25% of patients with brain metastasis progress to death due to the brain disease, showing how much we evolved in the last decades. It is part of history to remember that long ago the CNS impairment diagnosis meant to seal this patient’s overall survival prognosis in weeks.
Within the brain gliomas, which the predominance in the population is ten times smaller than brain metastasis, the attendance to radiosurgery is on selected cases, as the heterogeneous histologic subtypes and molecular profiles require a wide range of available treatments to ensure maximum overall survival with quality of life for patients.
In honor to the significance of this therapeutic modality, the SNOLA 2018 - STATE OF THE ART IN NEURO-ONCOLOGY chose to create a Radiosurgery Chair. Therefore, it is with great enthusiasm, that we invite all specialty colleagues in Neuro-Oncology to take part of this conference in São Paulo, on 15-17 March 2018. It is a unique opportunity to get acquainted with the specifications and results from radiosurgery in the treatment of neuro-oncology pathologies, especially regarding single and multiple metastasis. We elaborated a sophisticated programme, illustrating what is most modern in the integration of conventional radiosurgery and micro-neurosurgery. We count on innovative and opinion leader attendees in the radiosurgery field, bringing state of art procedures and techniques in radiosurgery for the treatment of these neuro-oncology diseases.
Be part of this and broaden our event with your presence and comments during our discussions!
I have the honor and pleasure to invite you to the 2nd SNOLA Congress, known as the greatest neuro-oncology event in Latin America.
We will discuss the latest developments in the area and acknowledge the best results of treatment regarding the Central Nervous System tumors.
The biggest Brazilian and international neuro-oncology names will be present, ensuring the highest level for this congress, which has been renowned for bringing guest speakers chosen for their knowledge and merits in their publications.
If you are a neurosurgeon or oncologist, you cannot miss this event. It will be a unique opportunity to refresh your professional knowledge and get in touch with the best in the world. Not to mention the possibility of exchanging and discussing ideas with colleagues from different countries.
I'll be waiting for you there.
A huge hug!
Jose Marcus Rotta
Tourism and Lodging
Don't worry about your hosting, let us take care of it for you!
Access and view options
the Main Dates
Fourth and last deadline for registrations at a discount value! After this, the values will be the same as the day of the event.